Overview HARVONI is indicated for the treatment of adults and pediatric patients 3 years of age and older with chronic hepatitis C virus (HCV) genotype (GT) 1, 4, 5, or 6 infection without cirrhosis or with compensated cirrhosis. HARVONI is used with ribavirin in GT 1 patients with decompensated cirrhosis and in GT 1 or...
Specialty Medications (Premium) Membership Required
You must be a Specialty Medications (Premium) member to access this content.
Already a member? Log in here